Mr Paschalidis faced three charges.
The first was that he failed to carry out an examination or vaccinate a dog called Beluga, but made entries in the clinical records for the dog indicating he had.
The second charge was that, on the same day, he failed to carry out an examination or vaccinate a cat called Simba, but made entries in the clinical records for the cat indicating he had, and told a veterinary nurse colleague that he had vaccinated the cat.
The third charge was that the conduct of Mr Paschalidis in relation to the other two charges was dishonest and/or misleading and that he was therefore guilty of disgraceful conduct in a professional respect.
The Committee found the charges relating to the failure to carry out an adequate examination and vaccinate Beluga and Simba proven.
The Committee also found that Mr Paschalidis had been dishonest and misleading in relation to his clinical records for Beluga.
Although Mr Paschalidis admitted the charge that he had failed to examine Simba, he denied that the record was misleading or dishonest as he said he'd been interrupted by a colleague whilst making the notes, rendering them an incomplete draft.
The Committee found it unproven that Mr Paschalidis had dishonestly made entries in the clinical records for Simba indicating that he had vaccinated him when he hadn’t.
Nor did it find that that Mr Paschalidis had been dishonest in his entries which indicated that he'd examined Simba, instead finding that his conduct was misleading.
However, having found that Mr Paschalidis was dishonest in his recording of his examination/vaccination of Beluga and that he was dishonest in relation to his communication of vaccination of Simba to a colleague, the Committee found that his conduct amounted to conduct falling far below that to be expected of a reasonably competent veterinary surgeon.
The Committee took into account eight testimonials, which were all positive about Mr Paschalidis’ character.
The Committee also noted his Continuing Professional Development (CPD) record, which, from February 2020 to February 2023, totalled over 170 hours.
It also considered that there was no evidence of actual harm to either Beluga or Simba, no evidence of any gains for Mr Paschalidis, and that the episode lasted no longer that one hour.
Against that, the Committee considered the risk of injury to the animals from not being vaccinated or examined adequately and the breach of client trust.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee assessed that the conduct of Mr Paschalidis, which included dishonesty, was in the upper middle range on the scale of dishonest conduct as the breaches of the Code of Professional Conduct were committed deliberately and for dishonest reasons, rather than through inadvertence or mistake.”
"The Committee decided that all of the mitigating factors, combined with an absence of any further incidents or similar behaviour having been drawn to the College's attention, alongside the positive testimonials, led it to conclude that the risk of any repetition of similar conduct was reduced such that Mr Paschalidis no longer poses a significant risk to animals or the public."
"The Committee considered that the misconduct found proved was sufficiently serious to require suspension from the Register, which would have a deterrent effect and would satisfy the public interest in this case.
"However, because Mr Paschalidis had continued to work as a veterinary surgeon for two years since these events without complaint and had shown some insight, the Committee decided that a lengthy suspension would not serve a useful purpose and would therefore be disproportionate. "
“The Committee therefore decided to direct that, as a deterrent, Mr Paschalidis’ registration be suspended for a period of six months.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
The British Association of Homeopathic Veterinary Surgeons is claiming that: "owners can now be confident homeopathic medicines can be effective for common canine and feline conditions in many animals, following a recently published clinical study."
In what the BAHVS says was the largest-ever study of its type, the Clinical Outcomes survey has identified a number of clinical conditions in dogs and cats that homeopathic veterinary surgeons believe may be promising targets for future research in veterinary homeopathy.
In the study, twenty-one homeopathic vets in the UK recorded data from their patients over a 12-month period, and collected information from a total of 1500 dogs and 400 cats. The most frequently treated feline conditions overall were dermatitis, renal failure, overgrooming, arthritis and hyperthyroidism. The most commonly recorded canine conditions were dermatitis, arthritis, pyoderma, colitis and fear. By owners' assessments, a moderate or major improvement was reported overall for 68% of dogs and 63% of cats.
The authors of the study concluded that a programme of controlled research in homeopathy for frequently-treated feline and canine conditions is clearly indicated.
John Alborough, co-publisher of VetSurgeon.org said: "I also find that if I shove toenail clippings up my bottom, it totally cures my indigestion."
ReferenceMathie RT, Baitson ES, Hansen L, Elliott MF, Hoare J. Homeopathic prescribing for chronic conditions in feline and canine veterinary practice. Homeopathy 2010; 99: 243-248.
The practice, which has nine clinicians (including three RCVS Recognised Specialists), eleven RVNs, two human-trained cardiac physiologists and a dedicated referral administrator is the first referral practice in the UK to become an EOT.
Dave Dickson, a director alongside Jo Harris, said: "The decision to transition the clinical side of the business into employee ownership was led by the core values of the team and the desire to preserve our independence as a referral service.
"In an industry dominated by corporate acquisitions, with business models increasingly focused on keeping referral offerings within the corporate groups and limiting choice for clients, we felt it was crucial to chart a different course.
"We have a very bonded and supportive team, working together to continuously improve and evolve, where the ideas of every team member are important and all roles are equally appreciated.
"We feel that employee ownership aligns perfectly with this ethos.
Jo Harris added: “By involving all our employees in the ownership of the business, we aim to foster a culture of engagement and collaboration.
"This new structure ensures that every team member has a stake in the success of the business and a voice in how it operates.
"We believe this will not only enhance our service quality but also promote sustainable growth and innovation.
"The transition to employee ownership is not just a change in structure; it is a reaffirmation of our values and a pledge to our patients, clients, and partners that we will continue to strive for excellence in every aspect of our work.”
https://heartvets.co.uk
When the Newmarket-based veterinary and scientific research charity launched the test, it was believed that one in twenty Petit Basset Griffon Vendeen puppies would grow up to be affected by POAG.
Three years later, through responsible breeders using the DNA test, the AHT says there have been NO affected puppies in the UK reported to The Kennel Club.
The AHT says the test results demonstrate how appropriate DNA testing can lead to the immediate disappearance of a recessive disease, improving the health and wellbeing of countless dogs and their families.
One breeder who has seen first-hand the benefits of this DNA test is Viv Phillips, who said: "As the breeder who first announced I had a dog affected by POAG I was delighted to work with the AHT and Prof Peter Bedford for 18 years in the research into this disease. I know how tough it is to not be able to avoid your dog going blind at a relatively young age. When the AHT discovered the DNA mutation in November 2014 which was subsequently launched at Crufts in 2015 it was the most wonderful result.
"I tested the PBGVs I still had, including their older parents, and was able to ascertain that puppies I had bred were either at no risk of going blind or sadly carried the gene and therefore treatment could be started to prolong their eyesight. Since this time I have bred 12 puppies and I am delighted that I know they will not be affected as a result of using the DNA test.
"Worldwide approximately 1800 Petit Basset Griffon Vendeen have been tested, and in the UK no puppies have been recorded as affected in the last three years. It is not a numerically large breed and if we can continue to spread the word worldwide and convince breeders to test their breeding stock, we can - with the help of the AHT - look forward to eliminating this awful disease completely."
Dr Cathryn Mellersh, Head of Canine Genetics at the AHT, said: "Years of work went into developing this DNA test which makes it even more rewarding to see it used so well to stop these lovely dogs from going blind. Glaucoma is a very debilitating and painful disease and some dogs have to their eyes removed as a result.
"We are studying glaucoma, and many other blinding diseases, in lots of dog breeds. These mutations can also affect cross bred as well as purebred dogs, so as the popularity of cross bred dogs continues to rise, DNA health testing is more important than ever to make sure you’re breeding, or buying, puppies that are going to have the very best start in life. Great things can be achieved through genetic research and as humans suffer many of the same diseases as dogs, there is always the possibility that our research is going to help human medicine as well. Unfortunately research is expensive and we always need more funding to be able to continue to maintain and expand our research of inherited diseases, including more complex diseases, such as epilepsy."
The study1 was led by the RVC’s VetCompass Programme and is the largest study using anonymised veterinary health records to explore dry eye in dogs. The study included 363,898 dogs that were followed for a year to identify 1,456 dogs affected with dry eye.
The study found that one in every 250 dogs overall is affected by the condition, but certain breeds are especially prone.
The worst affected breeds were: American Cocker Spaniel (5.90%), West Highland White Terrier (2.21%), Cavalier King Charles Spaniel (1.91), Lhasa Apso (1.86%), English Bulldog (1.82%), English Bull Terrier (1.65%,) and English Cocker Spaniel (1.60%).
Other findings included:
The authors of the study have recommended that vets help reduce the frequency and impact of KCS by testing for the adequacy of tear production as part of the annual physical examination of all dogs but especially for the list of predisposed breeds as they approach advanced age.
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and author of the paper, said: "We all love those glossy puppy dog eyes, but this study shows that sadly not every dog enjoys good eye health. This research identifies that flattened faces in some breeds makes these breeds more prone to this painful dry eye condition. Work is urgently going on to improve the health of many of these flat-faced breeds, but in the meantime the message from everyone who cares about dogs is to ‘stop and think before buying a flat-faced dog."
Rick Sanchez, European Specialist in Veterinary Ophthalmology says: "Taking a fresh dip into an old, dull looking disease like KCS has shown us there is more for us to learn than we thought. Ultimately, all of us, clinicians, nurses, researchers, breeders and dog owners are, in one form or another, care givers for our beloved animals. All of us need whatever new information we can set our eyes on to inform our next steps in improving canine ocular health. There’s no better eye opener than evidence-based scientific findings. I hope this research helps all of us raise awareness about canine KCS and that it helps us keep those animal eyes looking fresh and healthy, as they should.”
Bill Lambert, Health, Welfare and Breeder Services Executive at The Kennel Club commented: "These findings are important to help us to identify which dogs are most at risk of developing dry eye. Ultimately, this should help owners that may need support in spotting the initial signs, as well as ways to treat affected dogs and how to prevent it occurring in the future. The data from this fascinating research will also be used to collaboratively create strategies to tackle health priorities with the breed clubs of affected breeds."
Reference
Photo: Cavalier King Charles Spaniel with KCS. By Rick F Sanchez BSciBiol DVM DipECVO CertVetEd FHEA.JPG
Mr Chaney was charged with stealing Trazadone and Metacam from the Hampstead practice he worked at, and of unlawfully possessing Trazadone and Metacam. He was also charged with unlawfully administering Butorphanol to a dog and failing to record the administration of the drug in the dogs records. He was also charged with making and deleting false entries into the clinical records of his own dog to the effect that it had been seen by a vet at the practice and that Metacam had been prescribed. The final charge was that his conduct over the false records was dishonest and misleading.
The Committee heard that Mr Chaney’s conduct in relation to the first two charges was discovered when, in July 2018, the Department for Environment Food & Rural Affairs (Defra), accompanied by police officers, executed a warrant (for unrelated matters) on the property where he lived. During the course of the search, police officers found Metacam and Trazadone in Mr Chaney’s bedroom which did not seem to have a prescription and so Defra officers launched an investigation.
During the course of this investigation, a Defra investigator was also provided with a video and messages that indicated Mr Chaney had unlawfully administered Butorphanol to a Husky dog in frustration with the animal as it was being too noisy.
The Committee heard that, in November 2018, Mr Chaney accepted a police caution in relation to his possession of Trazadone and Metacam, and the unlawful administration of Butorphanol. The Committee also heard that following the police attending his property and finding the medicines, Mr Chaney went on to create false records at the practice in relation to the examination of his dog in order to justify his unlawful possession of the drugs.
The Committee found all the charges against Mr Chaney proven.
The Committee then went on to consider if the charges, taken both individually and in totality, amounted to disgraceful conduct in a professional capacity.
Judith Way, chairing the Committee and speaking on its behalf, said: "The Committee had no doubt that administering a sedative to an animal that required prescription by a veterinary surgeon and then failing to record it in the clinical record with the resultant risk to the animal’s welfare due to lack of knowledge of the administration fell far below the expected standard.
"The Committee also considered that possession of prescription only medicines by a registered veterinary nurse, without the sanction of law, having stolen the same from a practice also fell far below the expected standard.
“The Committee also considered that tampering with the clinical record for a dog, in order to create a misleading impression and in doing so dishonestly, was conduct which fell far below the expected standard.
“Taken as a whole, the Committee considered that Mr Chaney’s conduct had fallen far below the expected standard.”
The Committee therefore found him guilty of disgraceful conduct in a professional capacity in relation to all seven charges.
It next went on to consider what sanction, if any, to impose taking into account the aggravating and mitigating factors.
In considering the aggravating factors, the Committee took into account that Mr Chaney’s conduct had presented a risk of injury to the animal and that much of his conduct was pre-meditated. It also considered that Mr Chaney’s conduct involved a breach of trust to both the practice where he was employed and the owner of the Husky, and it was also an abuse of position in gaining access to and stealing medication. Lastly, because the charges related to two separate incidents, there was a common thread in Mr Chaney disregarding rules on veterinary medicines.
In mitigation, the Committee considered that Mr Chaney had reflected on and gained some insight into his behaviour, and acknowledged he had made admissions at the outset of the hearing, including apologising for and showing regret about aspects of his conduct.
However, the Committee did not believe he had addressed his understanding of the effect that this conduct had on the risk to animals, the standards of the profession or the maintenance of public confidence in the profession. In mitigation the Committee also considered a number of positive character references and his previous good character.
Judith Way said: “The Committee determined that it would not be sufficient in the circumstances of the case, to satisfy the public interest to suspend the Respondent’s registration. In its view this case involved a serious departure from identified professional standards. The disregard had been deliberate, in relation to ignoring legislation in respect of prescription-only medication and dishonesty in stealing medication.
"There was evidence of attitudinal issues in relation to that behaviour and insufficient evidence of the development of insight. The dishonesty in relation to the clinical record relating to dog O [his own dog] had been an attempt to conceal earlier dishonesty relating to the theft of the medication. In administering the Butorphanol to dog L [the Husky], Mr Chaney had been putting his own interests in quieting the dog ahead of the dog’s interests, which would have required checking with a veterinary surgeon as to appropriate steps.
"The Committee acknowledged that, by directing removal, there would likely be professional reputational damage to Mr Chaney and possible financial loss. However, in the view of the Committee the requirements of the public interest outweighed these factors.”
Accordingly, the Registrar of the RCVS was directed to remove Mr Chaney’s name from the Register of Veterinary Nurses.
Full details can be found here: https://www.rcvs.org.uk/concerns/disciplinary-hearings/
Leading equine veterinary surgeon Ian Wright has been setting a legal precedent this week, as the Court of Appeal ruled that his ex-wife could not expect him to continue to fund her lifestyle and that she should earn her own living.
Ian, an RCVS Specialist in Equine Surgery and a partner at the Newmarket Equine Hospital, divorced his wife Tracey in 2008 after 11 years of marriage. As part of the settlement, Mrs Wright was given a £450,000 house and Mr Wright was ordered to pay £75,000 per annum, which included £33,200 spousal maintenance.
Last year, Mr Wright, 59, went to the High Court to ask for a reduction in maintenance, arguing that it was unfair to expect him to continue to fund his ex-wife indefinitely, even after he retired at 65, when she made no effort to find a job and support herself.
The case was heard by Judge Lynn Roberts, who agreed there was no reason why Mrs Wright had not worked in the six years since her divorce and said she had been: "evasive on the subject of her own earning capacity".
Mrs Wright challenged the decision in the Court of Appeal this week, where Lord Justice Pitchford rejected her fight to have her future maintenance reinstated, saying: "There is a general expectation that, once children are in year two, mothers can begin part time work and make a financial contribution" and: "The time had come to recognize that, at the time of his retirement, the husband should not be paying spousal maintenance".
Speaking to The Times, Mei-Ling McNab, a partner at Brachers law, said: "This landmark decision provides some much needed clarity and will be a game-changer for future big-ticket divorce cases. The ruling confirms that mothers with children aged over seven should have financial responsibility to support themselves."
The hearing took place in Mr Prichard's absence after he failed to respond to Colleges attempts to contact him, including by email, post, telephone and personal service of documents.
However, in its decision to proceed in Mr Prichard’s absence, the Committee confirmed that it would not hold his non-attendance against him or attach any adverse inference to that fact.
Mr Prichard was charged with taking quantities of the controlled, prescription-only drug Vetergesic from the practice’s stock other than for legitimate veterinary use.
He was further charged that he took Vetergesic from the practice by drawing it into a syringe for the purposes of self administration, and that in doing so, his conduct was dishonest.
In another set of charges, it was alleged that on five separate occasions, Mr Prichard had attended the practice to work as a veterinary surgeon whilst unfit to do so.
The final charge related to Mr Prichard’s failure to respond adequately or at all to all reasonable requests from the RCVS for his response to concerns raised about his conduct.
At the beginning of the hearing Nicole Curtis, acting on behalf of the College, read the written evidence from 11 separate witnesses outlining the facts related to the charges against Mr Prichard, including the record of an investigative meeting held by the practice in which he admitted his theft and use of the controlled drug and following which, he was dismissed from his employment.
The Committee found all the charges proven and then considered whether they amounted to serious professional misconduct.
In terms of aggravating factors the Committee found that there was a risk of injury, recklessness, premeditated and sustained misconduct, and that there was an abuse of his professional position in accessing prescription-only controlled drugs for reasons other than legitimate veterinary use.
In mitigation, the Committee considered that he had made admissions as part of the practice’s internal disciplinary investigation.
Overall, the Committee found he had breached aspects of the Code of Professional Conduct related to honesty and integrity, making animal health and welfare his first priority, appropriate use of veterinary medicines, taking steps to address physical and mental health conditions that could affect fitness to practise, responding to reasonable requests from the RCVS, and bringing the profession into disrepute.
Therefore, the Committee found him guilty of serious professional misconduct in relation to all of the charges charges.
The Committee felt that, considering the seriousness of the misconduct, removal from the Register was the most appropriate decision.
Austin Kirwan, chairing the Committee and speaking on its behalf, said: “This is a case involving serious dishonesty, sustained over a period of time, and conduct potentially detrimental to animal welfare, as well as wilful disregard of professional regulations.
“Regrettably, Mr Prichard’s failure to engage with the College and with the regulatory process limited the options open to the Committee.
"Notwithstanding this, Mr Prichard’s disgraceful conduct is so serious that removal from the Register is the only means of protecting animals and the wider public interest which includes the maintenance of public confidence in the profession and the upholding of standards.”
www.rcvs.org.uk/disciplinary
Part 1 of "Comparison of veterinary drugs and homeopathy", by Peter Lees, Professor Emeritis in Pharmacology at the RVC, Ludovic Pelligand, Senior Lecturer in Veterinary Clinical Pharmacology and Anaesthesia at the RVC, Martin Whiting, Lecturer in Veterinary Ethics and Law at the RVC, Danny Chambers, an RCVS Councillor currently working at Langford Veterinary Services, University of Bristol, Pierre-Louis Toutain, a European Veterinary Specialist in Pharmacology and Toxicology, and Martin Whitehead Co- and Clinical Director at the Chipping Norton Veterinary Hospital, is published in last week's (August 12th) edition of the Veterinary Record.
The paper considers some of the reasons why medicinal products work and the errors in human thinking which make them seem to work when actually they don't. It also takes a look at the history of veterinary and homeopathic medicine, which helps explain how something as scientifically implausible as homeopathy ever gained traction in the first place.
VetSurgeon.org Editor Arlo Guthrie said: "As the parent of a child with a severe, chronic and highly variable disease, I’ve had prolonged first-hand experience of just how easy it is to fall prey to the sorts of errors in human thinking that can make you believe a treatment is working when in reality it is not. It’s something I continue to have to fight against, despite being well-educated about things like cognitive bias and regression to the mean.
"I believe all veterinary surgeons, and doctors for that matter should constantly remind themselves of these errors and importantly keep them front of mind when advising clients. Not just so they can explain cogently why quack medicine offers nothing more than false hope and a thinner wallet, and why randomised, double-blind, placebo-controlled trials are so important, but also to improve their own assessment of a patient’s response to treatment."
The paper can also be downloaded here: http://veterinaryrecord.bmj.com/content/181/7/170
Part 2 of the paper is due to be published in next week’s edition of the Veterinary Record.
STOP PRESS VetSurgeon.org has funded the Open Access publication of this paper, so both parts are now available for all to read here:Part 1: http://veterinaryrecord.bmj.com/content/181/7/170Part 2: http://veterinaryrecord.bmj.com/content/181/8/198
Photo: The father of homeopathy, Samuel Hahnemann, Wikipedia
Harrison Family Vets opened its first practice earlier this month in Woodley, Reading, in a £350,000 investment that created eight jobs.
The plan is for the next practice to open later this summer in the Midlands, before the group expands north towards the end of the year. The group is now searching for further properties across the north and south of England, with plans to open 75 practices by the end of the decade.
Tim joined his dad's practice in 1995 as General Manager. He later co-founded Vets4Pets in 2001 before joining Mars Inc. to head the overseas growth of Banfield, then the world’s largest veterinary practice. He then rejoined the family business to grow it further, until it was acquired by IVC Evidensia in 2018.
Alongside Tim is operations director, Kristie Faulkner who also worked at White Cross Vets until it was acquired by IVC, whereupon she became regional operations manager, overseeing more than 200 of the IVC's practices across the South East of England.
Between 2012 and 2018, White Cross Vets was repeatedly named as one of the UK’s best employers and a truly extraordinary place to work. The company secured a place in the prestigious ‘Top 100 Sunday Times Best Small Companies to Work For’ league table for seven consecutive years, as well as being the inaugural SPVS Wellbeing Award Winners.
Tim said: “The whole ethos at Harrison Family Vets is about fostering a culture within our team that sets us apart and differentiates our practice from all others. Every individual’s strengths and personality traits will contribute to what we do, in a family-orientated environment. Our culture is about looking after people. Focus on attracting the very best people and then look after them as much as possible. A successful practice with a fabulous reputation amongst the profession and amongst clients is what automatically follows.
“Our state-of-the-art clinics boast extensive facilities including on-site laboratories, full x-ray suites, operating theatres, ultrasonography and separate dog and cat wards that have been carefully designed with mood lighting, aromas and music to offer a calming atmosphere.
We’ve also worked hard to create a customer experience that’s more akin to an Apple store, than a traditional veterinary practice. We don’t have a reception desk and instead, our front of house team have the autonomy to freely interact with our clients and their pets.
Our waiting areas feature bespoke pods, which give clients their own space and offer pets privacy, thus shielding them from the stresses of facing other pets in a traditional waiting room. Each pod also has its own tablet where clients can update their details, sign up to our Total Wellness Plan or even order fresh and healthy dog food from Butternut Box.
“Everyone wants to know why we want to start another veterinary group now. For Kristie and I the timing is perfect as there is a clear void to fill. The people-focused independent practice is becoming a thing of the past and is what the profession is yearning for. This will attract the very best team members which in turn will provide a superior client and pet experience.
"Creating a successful business and building a fantastic team is incredibly exciting and we genuinely believe Harrison Family Vets can become the most innovative, forward-looking and caring practice, as well as the employer of choice for vets and nurses, in the UK.”
VetSurgeon.org wishes Tim and Kristie all the very best luck in the world with their new venture, although one suspects that they won't need to rely on luck. White Cross under his direction was consistently doing extraordinary things to foster what seemed to be a remarkably good working environment. If they can come close to repeating the formula, or improving on it, they must be on to a winner.
Having investigated alternative sources of isoflurane, and alternative products, the associations proposed ways that the VMD might mitigate the risks to animal welfare including consenting to the use of unlicensed (“special”) isoflurane formulations.
The VMD responded rapidly and positively. It is understood that one specials manufacturer is now intending to produce isoflurane to fill or partially fill the gap in supply. This should be available in three to four weeks.
David Rendle, a member of BEVA’s Health and Medicines Committee commented: "BEVA has a close relationship with the veterinary pharmaceutical industry and will always work swiftly and collaboratively to help develop practical solutions to supply problems for our members."
BSAVA President Philip Lhermette praised the VMD for such prompt action. He said: "The VMD listened to our concerns and acted immediately. By doing so they have addressed and helped to prevent any potential welfare risks associated with a lack of isoflurane."
Carl Bradbrook, AVA Junior Vice President, reminded clinicians to "seek advice when considering the use of unfamiliar anaesthetic protocols."
The associations say that the situation doesn’t give vets free rein to ignore the medicines legislation; the cascade must still be followed, and client informed consent obtained if an unregulated anaesthetic is used.
Extemporaneous products are the last tier of the cascade. Vets are expected to use either an authorised human medicine or an EU authorised veterinary medicine before an extemporaneous preparation. If, after diligent attempts to source a product higher up the cascade, the vet has not been successful they could consider using an extemporaneous preparation for the immediate need. However, should an authorised product or a human product become available vets are obliged to use it over an extemporaneous preparation.
BEVA, the BSAVA and the AVA have each produced general advice on the use of specials or anaesthesia options at https://www.bsava.com/News/ArticleID/2535/Isoflurane-supply, https://www.beva.org.uk/Resources-For-Vets-Practices/Medicines-Guidance/Veterinary-specials and https://ava.eu.com/
Bovalto Respi Intranasal protects against the two main respiratory viruses – RSV and PI3, using modified live viral strains that have been shown to protect against experimental challenge from recent field isolates1.
The vaccine is delivered as a single shot, from 10 days of age and provides immunity for 12 weeks, from 10 days after vaccination2.
In order to overcome the challenges of effective delivery, Boehringer is offering dedicated administration packs, available directly from its ruminant specialist team.
The packs include a vaccinator, a set of nozzles that deliver the vaccine at the optimum droplet size and a soft Bovalto Respisafe applicator which fits against the calf’s nostril. The aim is to make sure that vaccination is a comfortable process for both farmer and calf, as well as addressing the challenge of the delivery of vaccine to the desired area in the nasal passages.
Correct administration of the vaccine ensures that the spray is delivered effectively to the mucosal surface and local lymphoid tissue, achieving the optimal immune response. If the droplet size is too big, the vaccine may be deposited lower in the airway and run out of the nose. If droplet size is too small then the vaccine may be carried to the back of the throat and swallowed. Time and money is spent vaccinating calves so the process needs to be as efficient as possible to give optimal protection.
Matt Yarnall, brand manager at Boehringer Ingelheim said: "The UK BRD vaccine market is growing each year but, as a management tool, vaccination remains quite low down the list of actions, according to the 2017 Calfmatters survey.
"If adding to the Bovalto range encourages more farmers to vaccinate against pneumonia so improving calf heath and lowering antibiotic use, that can only be a step in the right direction."
References
The petition was set up by veterinary surgeon and journalist Pete Wedderburn, after discussion with colleagues, in response to an open letter to the profession from Jemima Harrison, producer of the Pedigree Dogs Exposed documentary broadcast in 2008.
In the letter, Jemima notes that Kennel club registrations of Pugs rose from 2,000 in 2005 to 10,000 last year. Over the same period Bulldog registrations more than doubled to 7,000 and the number of French Bulldogs increased 4000% to 14,607.
All vets do, she says, is 'organise CPD days on how to manage the increasing numbers of creatures that turn up at your practice doors gasping for air', 'refer clients on to soft-tissue specialists who do their best to remedy the deformity that has been bred into them', and 'section that Bulldog and say nothing to the breeder about how wrong it is that the dogs are no longer capable of birthing their own pups'.
She argues that there is 'institutional kow-towing to the Kennel Club and a reluctance to do anything other than accept their platitudes that they have to take things slowly or risk "losing" the breeders'.
In response, Pete's blog and petition calls for a working party to develop concrete proposals to tackle the issues as a matter of urgency: 'Despite the evident appeal of short-nosed pets to many of our clients, it is our duty as vets to not just treat these animals, but also to lobby for reform in the way they are bred – in particular the 'extreme' brachycephalics such as Pugs, Bulldogs, French Bulldogs and flat-faced Persian cats'.
The Dog Breeding Reform Group has welcomed the petition. Chris Laurence MBE, DBRG Trustee and former veterinary director of the Dogs Trust who has signed the petition, says: "Vets in companion animal practice see dogs with inherited breathing difficulty almost every day and are frustrated that there seems to be no end to the daily suffering of these breeds. The DBRG is delighted that vets are now getting together to highlight the issue and to plead with breeders to stop producing puppies with such malformed heads that they are unable to breathe easily."
The petition, which has already gathered nearly 1000 signatures, can only be signed by veterinary surgeons and nurses. You can sign it here.
NEV was first identified in 2013 by veterinary surgeon Dr Isabel Fidalgo Carvalho, who went on to found Equigerminal to develop a commercially viable NEV diagnostic test that can be used by veterinary surgeons, vet labs and horse owners.
Isabel says that NEV - the equine equivalent of HIV - is often misdiagnosed or hidden by other diseases that induce similar symptoms, like anaemia and neurological issues in horses. It is most commonly confused with the Swamp Fever virus (EIAV) and Equine Herpesviruses (EHV).
Indeed, when they tested a number of horses with anaemia, Equigerminal researchers first believed they had found the presence of a divergent strain of the Swamp Fever Virus (EIAV) - because the horses cross reacted with EIAV, but were negative in the official tests. Subsequent research found they were actually suffering from NEV.
Equigerminal says it is believed that NEV is present in up to 10% of horses. Isabel said: "We did test 213 samples from Ireland and found 7% of positive samples for NEV. These Irish horses were horses that usually travel to UK and other locations for sports events."
For the new test, a veterinary surgeon needs to take a blood sample which is sent to the Equigerminal lab.
Isabel says treatment is currently targeted towards improving the general well-being of the horse, health monitoring, and boosting the animal’s immune system. The next stage is to find a treatment, and ideally a cure for NEV. Meantime, Isabel said: “We now need to raise awareness of the problem and help vets to diagnose this disease correctly.”
RIP Fleas, the environmental flea treatment from Genitrix, has been given a new formulation to ensure it acts more quickly in the killing of adult fleas and that it continues to kill fleas as they emerge from pupae for up to 12 months.
Now known as RIP Fleas Extra, the product is also licensed for the control of house dust mites in the environment for up to 12 months.
According to Genitrix, the reformulation makes RIP Fleas Extra the only environmental flea treatment to contain three active ingredients while complying fully with new EU Biocides regulations. It is the only such treatment to be fragranced and is also the only product to be presented in a volume which will cover 120 square metres – ie the size of an average house. RIP Fleas Extra contains:
Tetramethrin – a second generation synthetic pythrethroid and a contact insecticide with a rapid knockdown action of insect pests
Permethrin – a potent insecticide with a powerful contact action on insects but with a low toxicity to most mammals
Methoprene – a compound that mimics the insect juvenile hormone and arrests development of fleas and house dust mites in the environment.
When used synergistically, Tetramethrin and Permethrin provide a rapid knockdown and kill of fleas as they hatch from pupae. Studies have shown that this combination works four times more quickly than Permethrin alone.
The Disciplinary Committee heard that Mr Samuel had been convicted of five animal welfare offences at Leeds Magistrates' Court in January 2016. The charges related to causing unnecessary suffering to a number of animals including twelve dogs and four cats, and failing to take steps to ensure that the needs of the animals for which he was responsible were met. The animals were kept at the Armley Veterinary Practice, for which Mr Samuel was, at the time, practice principal.
Mr Samuel was sentenced to 12 weeks' imprisonment suspended for 12 months on the condition he completed 150 hours' unpaid work and paid a fine of £100. He was also ordered to pay costs of £500 and a victim surcharge of £80. He was also made subject to a disqualification order for three years.
Dr Samuel subsequently appealed against his conviction in April 2018. His appeal was dismissed in respect of five of the charges but was upheld in respect of one charge, which, as a result, did not form part of the College’s case.
Dr Samuel declined to attend the hearing in person and was not represented before the Disciplinary Committee. In considering the facts of the charges against Dr Samuel the Committee found them proven.
The Committee then went on to consider whether the proven charges, both individually and cumulatively, rendered Dr Samuel unfit to practise as a veterinary surgeon.
The College’s case was that the convictions concerned animal welfare and therefore went to the heart of his practice as a vet, that Dr Samuel behaved in a manner incompatible with being a veterinary surgeon, that he failed in his core responsibility as a veterinary surgeon to protect and act in the best interests of animal welfare, and that he maintained he had no responsibility for the animals on his practice premises – an assertion referred to as ‘an extraordinary position for a veterinary surgeon to take’.
Ian Green, chairing the Committee and speaking on its behalf, said: "ust as the judgment of the Crown Court and the Magistrates Court had found, the Committee also found that Dr Samuel must have known that the animals were in distress and were in a neglected state. The Committee was sure that Dr Samuel must have been aware of the animals notwithstanding his continued denial. The Committee concluded that Dr Samuel was unfit to practise because of the facts underlying the convictions. Dr Samuel had an overriding duty of care for the animals and to take action in relation to their health and welfare because they were living under the roof of his veterinary practice."
In considering its sanction against Dr Samuel, the Committee concluded that removal from the Register was the most appropriate option. It took into account the fact that the animals were found starving in a cellar without water, that Dr Samuel had not demonstrated insight into the serious nature of his offences, that he continued to deny responsibility and, furthermore, found no evidence that he no longer posed a risk to animals in the future.
Ian Green added: "The Committee decided that the behaviour found proved was fundamentally incompatible with being a veterinary surgeon because in this case there had been a serious departure from standards as set out in the RCVS Code of Professional Conduct for Veterinary Surgeons…. Furthermore, there had been serious harm caused to a number of animals and a risk of harm to a number of other animals."
Dr Samuel has 28 days from being informed of the Disciplinary Committee’s decision in which to make an appeal to the Privy Council.
The Committee’s full decision and findings can be found here
The company says that Anallergenic can be used as the elimination diet of choice when working up dermatosis cases. Nutrient intolerance can be determined by feeding the extensively hydrolysed elimination diet for six to eight weeks followed by reintroduction of the pet’s original diet.
For cases where a nutrient intolerance is proven, Royal Canin says Hypoallergenic should be used for long-term nutritional management, although some refractory cases may need to remain on Anallergenic.
Anallergenic has been formulated with feather protein hydrolysate, starch instead of whole cereals and a combination of ingredients to help reduce water loss through the skin and strengthen the barrier effect of the skin.
John O’Connor, Veterinary Marketing Manager at Royal Canin, said: "When a nutrient intolerance is suspected, the cat’s diet should be changed to Anallergenic without any food transition. Dermatosis is complex to understand and identifying the underlying cause can be challenging. Managing cats with dermatosis requires a long-term commitment and it is essential for vets to use nutrition as part of their work up.
"The lower the allergenic potential of the diet, the more reliable the results¹ and nutritional management with Anallergenic can be continued for the cat’s lifetime. With the new, highly palatable² Feline Anallergenic diet, Royal Canin offers the complete nutritional approach to dermatosis."
Alongside the new diet, Royal Canin has produced a range of owner education materials, including a leaflet with top tips and a video about nutrient intolerances to raise awareness of the condition and the importance of owners seeking veterinary advice. The new materials are available via your Royal Canin Veterinary Business Manager.
For more information, visit royalcanin.co.uk/skin
Bayer has introduced a new microchip scanner which is capable of reading all chips, including encrypted ones.
The company says the new Tracer Advance Isomax V scanner offers exceptional reading distances of more than twice those of other scanners on the market, making it a very versatile tool ideally suited for use in companion animal practices or for detecting microchips in larger animals such as horses.
The technology that gives this scanner its backward compatibility with non ISO standard chips means practices can now save money by only having to buy one scanner, whereas previously two were required to be able to read all types of chip.
Other features of the device include digital signal processing (DSP), which protects against radio interference from TVs and PCs, and connectivity via USB, RS232 or optional Bluetooth interface.
The Tracer Advance Isomax V scanner is available from Bayer and is priced at £499.95. It comes with a 30-month warranty. Contact your Bayer territory representative for further details.
The updated guidance follows a public campaign known as ‘Tuk’s Law’, which was started after a healthy dog by that name was euthanased despite its microchip being dually registered with a rehoming centre as a 'rescue backup'.
In response, the RCVS and the BVA agreed that more should be done to prevent occasions where a dog might be needlessly put to sleep, but voiced concerns that a legislative approach could undermine a vet’s clinical judgement, unfairly involve veterinary surgeons in ownership disputes or potential criminality, and leave vets unfairly exposed to financial sanctions.
In consultation with Defra, the RCVS and BVA therefore jointly agreed to strengthen the Code of Professional Conduct as follows:
Chapter 8 (para 8.9)
There may be circumstances where a request is made by a client for the destruction of a dog, where in the clinical/professional judgement of the veterinary surgeon destruction of the dog is not necessary, for instance where there are no health or welfare reasons for the dog to be euthanised.
In these circumstances, before carrying out the request for euthanasia the veterinary surgeon should scan the dog for a microchip and check the relevant database if a microchip is found.
Chapter (paras 29.25 -29.27)
Clients may have a contract with the shelter from which they acquired the dog such that it can be returned to that shelter, and that it may be appropriate to discuss this with them prior to euthanasia. Alternatively, there may be another individual willing to take responsibility for the dog (who may be named on the microchip database), and this may also be discussed with the client.
The updated guidance supports existing best practice in terms of discussing alternatives to euthanasia with clients, and give vets flexibility where, in their professional judgment, scanning is not appropriate; this might be if scanning would itself cause a welfare problem, or where a vulnerable client might be involved.
The RCVS Standards Committee says it recognised the difficulties experienced by veterinary surgeons in dealing with the current microchip database system, but felt that introducing these provisions into the guidance was a more proportionate response than the alternative of legislation with substantial fines.
BVA Senior Vice President Dr Daniella Dos Santos MRCVS said: “One of the most important jobs as a vet is having those difficult conversations with clients about euthanasia where we talk through all the options that are in the animal’s best interests. But where the vet doesn’t consider that euthanasia is necessary, the new guidance clearly sets out the steps we need to take. We support this constructive approach that addresses the campaigners’ concerns without undermining veterinary judgement.”
ITV's Tonight programme broadcast last night portrayed a veterinary profession in which overcharging is commonplace.
Researchers for the programme took three healthy animals (a cat, a dog and a rabbit) to a number of different vets, telling them that the animals were off their food. The advice they were given varied. In the case of the rabbit from no treatment necessary, to dental work under general anaesthetic.
TV vet Marc Abraham then looked at each animal and told viewers that the correct advice in each case would have been the least expensive.
The programme also highlighted the substantial savings that pet owners can make by buying drugs online, and questioned whether the penalty meted out to a vet that had committed malpractice was sufficient (the vet had been struck off for 14 months, where presenter Jonathan Maitland argued it should have been for life).
Veterinary business consultant Mark Moran said: "So often, vets rely to a large degree on what owners are telling them, and the degree to which they insist the animal is ill, or off its food, will affect the advice and treatment given. Marc Abraham had the luxury of being presented three animals that he knew to be perfectly fit and well."
However he agreed wholeheartedly with the response from RCVS President Jill Nute this morning, that the thing both vets and pet owners need to learn from the programme is "the importance of communicating with each other".
Mark said: "It's a question of managing people's expectations. There'll always be a variance in the advice being given, but being up-front and open will help mitigate the risk of being accused of overcharging".
Click here to watch the programme. Click here to read the reactions to Marc Abrahams' blog
A vet from Texas hit the headlines this weekend after allegedly killing a feral cat with a bow and arrow and then posting photographs and bragging about it on Facebook.
According to various news reports, Kristen Lindsey DVM's post quickly went viral, and one of two Facebook pages set up in response - Justice for Cat Murdered By Kristen Lindsey - has already attracted over 35,000 likes. There are also petitions to revoke her license on thepetitionsite.com and change.org which have each gathered around 18,000 signatures thus far.
Sky News reports that Ms Lindsey was quickly fired by her employer, the Washington Animal Clinic, which issued a statement on Facebook.
The veterinary clinic's website and Facebook page are both currently unavailable.
16 clinics are affected by the investigation, namely Penrose Veterinary Group Limited, Kevin Castle (Pet Care) Ltd, Swayne & Partners Ltd, Treforest Veterinary Clinic Ltd, Mercer & Hughes Limited, Swaffham Veterinary Centre Limited, Anglesey Pet Clinic Ltd, Chiltern Equine Clinic.
It's not the first time, of course, that the CMA has intervened in the veterinary profession.
Earlier this year, it investigated the acquisition of Quality Pet Care (trading as The Vet) by CVS, and then Vet Partners' acquisition of Goddards, which led to CVS selling The Vet and Vet Partners selling eight of the 47 Goddards sites to Linnaeus.
An IVC spokesperson said: “IVC Evidensia is working closely with the CMA and engaging constructively with this review."
The Statutory Membership Examination must be taken by all individuals educated outside of the UK whose veterinary qualification is not recognised by the RCVS. Passing the exam allows them to join the UK Register, and practice as a veterinary surgeon in the UK.
The exam has existed in its current format for over 30 years, and the review was implemented to ensure the examination remains fit for purpose, and sits in line with international best-practice and the College’s current Day-one Competences.
The College says the review was also designed to make sure it is using the most appropriate means of assessment methods, to best prepare candidates for success, and to ensure candidates can work in the UK to the best of their ability.
The written examination will now consist of two parts; a clinical Multiple Choice Question (MCQ) paper (in a single best answer clinical vignette format) and an open book examination, which will be used to ascertain the candidate’s knowledge of the RCVS Code of Professional Conduct.
The Clinical, Practical Examination will now exist in the form of a multi-dimensional Objective Structured Clinical Examination (OSCE). This examination is set to measure a range of clinical, technical and professional skills including clinical reasoning, communication, professionalism, and ethical awareness. Following a tender process, Glasgow Veterinary School has been awarded the contract to host the OSCE examination for five years from 2019 to 2023.
RCVS Examinations Manager, Victoria Hedges, said: "The review of the Statutory Membership Examination has provided us with the opportunity to ensure that we continue to test the skills and knowledge needed to work effectively in a veterinary practice in the UK in a robust manner, and bring it in line with the final year examinations delivered at UK vet schools. In designing the examination, the RCVS has considered international best practice, in addition to approaches to regulatory examinations within both the veterinary and medical sectors."
A comprehensive handbook regarding this new examination will be available on the Statutory Membership Examination section of the RCVS website (www.rcvs.org.uk/statutory-membership-exam) shortly.
If you have any questions, please get in contact with Examinations Manager, Victoria Hedges: v.hedges@rcvs.org.uk
According to the authors, Miniature Schnauzers positively shone in their averageness in this study, because they were not commonly affected by any specific breed-related health problems.
In other words, the illnesses suffered by Miniature Schnauzers are just the common or garden things like dental disease, obesity, anal sac impaction, vomiting and ear infection, which can affect all dogs.
The study, which the authors say was the largest ever study of the breed, analysed 3,857 Miniature Schnauzers from a population of over 450,000 dogs across the UK. Its findings were that:
The average lifespan of Miniature Schnauzers was 11.7 years, which is similar to the average of 12.0 years for dogs overall.
The average adult bodyweight of Miniature Schnauzers was 10kg. Males on average were heavier than female breeds (11kg vs 9kg).
The most common disorder affecting the breed was dental disease (affecting 17.4% Miniature Schnauzers). This is similar to that of other similarly-sized breeds such as the Cavalier King Charles Spaniel (15.2%) and Border Terrier (17.6%).
Female Miniature Schnauzers are more likely to have dental disease, obesity/overweight and heart murmur. However, males are more prone to diarrhoea and claw injury.
The most common causes of death were neoplasia (14.7%), collapse (13.3%), mass-associated disorder (10.7%) and brain disorder (10.7%).
Dr Dan O’Neill, Senior Lecturer in Companion Animal Epidemiology at the RVC and Vet Compass researcher, said: "To do their best for their dogs, owners need to know what aspects of their dog’s health are the most important to protect. Thankfully, we now have the data to identify these: owners of Miniature Schnauzers and also dogs overall should pay special attention to dental care, weight management, anal sac issues and making sure their dogs eat a healthy diet."
"Based on VetCompass Programme data, the Miniature Schnauzer is currently Britain’s most average dog from the breeds that we have studied to date. Extreme breeds such as flat-faced, long-backed or teacup-sized dogs may currently be in vogue but we need to move away from extremes and towards the healthier middle-ground."
Dr Alex Gough of Independent Vet Care and co-author added: "Although a number of diseases were identified in the current study that affect Miniature Schnauzers, the commons ones did not occur more frequently in this breed than in others studied. Many popular breeds are prone to life-threatening and distressing conditions related to their breeding. Our study suggests that the Miniature Schnauzer should be considered as a relatively healthy breed, which can help owners make a decision when acquiring a new dog."
Bill Lambert, Senior Health and Welfare Manager at the Kennel Club, said: "The Kennel Club currently recognises 221 different breeds and registering these breeds with the Kennel Club provides opportunities for data to be collected so that it can contribute to high quality and large scale research, such as this study by the Royal Veterinary College.
'It is vitally important that this type of research is carried out so that breed specific information is gathered and can be made available to owners to help ensure their dogs are kept as fit and healthy as possible.
'The Miniature Schnauzer is a popular breed in the UK so being the ‘most average dog’ in terms of health, and having no breed specific health problems, is actually a good quality and is very welcome news.”
Dechra Veterinary Products has announced that it is to relaunch Fuciderm Gel, the topical skin product used to treat surface pyoderma in dogs, as Isaderm.
Isaderm contains fusidic acid, which Dechra says is highly effective against the bacteria Staphylococcus pseudintermedius, and the steroid betamethasone, which is both an anti-inflammatory and anti-pruritic.
Available as a white translucent gel in 15 g and 30 g tubes, Isaderm is a topical treatment which can be applied directly and stays on the affected area - the base of Isaderm is a carbomer gel which maintains contact on skin and wet lesions.
Dechra Dermatology Brand Manager Roger Brown said: "Fuciderm is one of our most popular products. As part of an international Dechra rebranding programme the name will now be Isaderm® but veterinary professionals can be assured that the only thing about the product that has changed is the name.
"This treatment was the subject of a multi-centre UK trial* comparing treatment of surface pyoderma with the gel or systemic therapy, and the gel product was shown to be as effective as systemic therapy."
For further information, visit www.dechra.co.uk